AMIIF-FIFARMA Innovation Week, 28-30 March 2023
To commemorate their anniversary, AMIIF will be holding the traditional innovation week. This year it is organised in conjunction with the Latin American Federation of the Pharmaceutical Industry (FIFARMA). There will be participation from several international speakers from WIPO, IFPMA and other organisations including Interpat.
UNPRECEDENTED: The Rapid Innovation Response to COVID-19 and the Role of IP
This report tells the story of how COVID-19 vaccines and treatments were rapidly developed and delivered to society, focusing on the enabling role of IP.
INTERPAT Innovation Seminar, 14-15 November 2022, Mexico City, Mexico
INTERPAT Innovation Seminar, 23-24 November 2021 (virtual)
The Economic Impact of Changing the Environment for Innovation in Argentina- Applying the lessons of Asia to Latin America
IP Pact
Medical innovations driven by the biopharmaceutical industry have played a fundamental role in helping people live longer, healthier lives. As the global population’s health needs become increasingly complex, it is ever more essential that we research and develop life-saving medicines and vaccines to meet these challenges.
Intellectual Property (IP) has been central to great scientific advances and for ensuring that patients have access to this innovation. IP helps foster long term investment to benefit patients – today and tomorrow.
During World Intellectual Property Day on 26 April 2021 the IP Principles for Advancing Cures and Therapies (IP PACT) were launched by members of the innovative biopharmaceutical industry. The IP PACT is an unprecedented declaration affirming the industry’s strong commitment to putting patients at the heart of their approach to IP.
